Business bank account for telehealth providers with an Estonian company

Our process begins with a detailed review of your Estonian OÜ structure, focusing on the ultimate beneficial owners (UBOs), their residency, and the source of funds for the business. For telehealth, this includes verifying the operational model, from patient onboarding to clinician licensing and data handling. We ensure your business plan clearly articulates the services offered, target markets, and expected transaction flows.

We then assemble a full KYB (Know Your Business) package tailored for financial institutions. This file presents your telehealth operations in a format that compliance teams expect, addressing sector-specific risks like patient data protection and prescription policies upfront. It includes corporate documents, UBO verification, clinician licences, and projections, demonstrating that the business is lawful, well-managed, and licensed where required.

With this robust file, we introduce you to appropriate EEA-licensed EMIs and banks that have an appetite for telehealth and are comfortable with Estonian e-Residency structures. We prepare you for the compliance interview, manage follow-up questions, and guide you through the onboarding process. After the first account is live, we typically scope a second provider to build resilience.

Underwriters for telehealth companies focus on five key areas. First, they scrutinise the source of funds for the business and the source of wealth of the UBOs to ensure all capital is legitimate. Second, they analyse your business plan and financial projections to understand the commercial logic and scale of the operation.

Third, compliance teams assess the specific risks of your telehealth model. This involves checking your policies for handling patient data (GDPR), your procedures for verifying patient identity, and, if applicable, your policy on prescriptions. Businesses involved with controlled substances face a much higher level of scrutiny and require specific licensing. We do not place telehealth firms that facilitate prescriptions without the proper medical oversight.

Fourth, they examine your geographic exposure, looking at where your patients and clinicians are located. Serving high-risk jurisdictions can complicate an application. Finally, for an Estonian entity, they will assess the level of genuine substance and management control within the EU. They need to be confident the structure is not merely a brass plate but has a tangible connection to its area of operation.

Using an Estonian private limited company (OÜ), particularly one established via e-Residency, presents specific challenges and opportunities. While the e-Residency programme makes incorporation straightforward, Estonian domestic banks are extremely cautious about onboarding companies with non-resident owners. They have a very low risk appetite for structures where management and operations are located outside Estonia. Therefore, for most e-residents, the primary account solution lies with EEA-licensed electronic money institutions (EMIs) rather than traditional Estonian banks.

These EU-based EMIs are accustomed to the e-Residency model but will still demand evidence of a genuine nexus to the EU. This can be demonstrated through EU-resident directors, key staff in the EEA, or a significant European customer base. The Estonian Commercial Register provides transparency, and providers will expect the entity to be in good standing with all annual reports filed. Your company's income is subject to corporate tax only upon profit distribution, a feature providers understand, but they will still expect clarity on the UBO's tax residency and source of wealth.

Unlike jurisdictions such as Georgia, which sit outside the SEPA zone, an Estonian company's EUR account benefits from seamless payments across Europe.

Accounts for telehealth providers are often declined because the application fails to build trust with the compliance team. A common reason is a weak business plan that lacks detail on patient verification, data privacy, and the scope of medical services. Providers see ambiguity as risk, so a file that does not clearly explain how you manage patient data under GDPR or how clinicians are licensed for the jurisdictions they serve is likely to be rejected.

Another major red flag is any association with the unregulated sale of prescription medications. Financial institutions are highly sensitive to this, and any hint that your platform facilitates prescription drug access without robust clinical oversight will lead to an immediate decline. We will not work with businesses that cannot provide clear licensing and prescribing policies.

For Estonian OÜs specifically, closures often relate to a perceived lack of substance. An institution may approve an account initially but later flag it if the company shows no genuine operational ties to the EU, appearing to be just a mailing address. This is why our approach focuses on documenting and proving a real EU nexus from the outset, ensuring the structure is sustainable and defensible under compliance reviews.

For an Estonian telehealth company, the timeline to a live account typically ranges from two to eight weeks. This depends on the complexity of your ownership structure, the UBO's profile, and the chosen institution's backlog. A well-prepared file with all clinician licences, corporate documents, and a clear business plan can significantly shorten this timeframe.

The onboarding process begins with the submission of our comprehensive KYB package. The provider's compliance team will review the file, which is usually followed by a video interview with the UBOs. This is a critical stage where we help you prepare to answer questions about your business model, risk controls, and EU substance confidently.

Once the account is live, maintaining a good relationship with the provider is crucial. This involves keeping your corporate information updated, including any changes to directors or UBOs. It is also important to use the account in line with the activity described in your business plan. Any significant deviation, such as a sudden pivot in services or processing unexpected volumes from high-risk countries, can trigger a compliance review and risk account suspension or closure. We advise on how to manage this relationship for the long term.